Estrogens and Parkinson disease: Neuroprotective, symptomatic, neither, or both?

Keyphrases

• Parkinson's Disease 100%
• Estrogen 100%
• Neuroprotective 100%
• Neuroprotective Role 40%
• Selective Estrogen Receptor Modulators 40%
• Etiology 20%
• Cell Death 20%
• Neurodegenerative Diseases 20%
• Interventional Study 20%
• Laboratory Data 20%
• Neurotrophic Factors 20%
• Epidemiologic 20%
• Modulatory 20%
• Antioxidant 20%
• Substantia Nigra 20%
• Bradykinesia 20%
• Dopamine Cells 20%
• Postural Instability 20%
• Neurotrophic 20%
• Anti-apoptotic Agent 20%
• Modulating Agent 20%
• Neuroprotection 20%
• Rest Tremor 20%
• Estrogenic Effect 20%

Medicine and Dentistry

• Parkinson's Disease 100%
• Neuroprotective Agent 100%
• Selective Estrogen Receptor Modulator 40%
• Cell Death 20%
• Neurotrophic Factor 20%
• Clinical Study 20%
• Neurodegenerative Disorder 20%
• Retrospective Study 20%
• Antiapoptotic 20%
• Antioxidant 20%
• Neuroprotection 20%
• Substantia nigra 20%
• Bradykinesia 20%

Neuroscience

• Parkinson's Disease 100%
• Neuroprotective Agent 100%
• Selective Estrogen Receptor Modulator 40%
• Cell Death 20%
• Tremor 20%
• Neurodegenerative Disorder 20%
• Neurotrophic Factor 20%
• Antioxidant 20%
• Substantia nigra 20%
• Bradykinesia 20%
• Neuroprotection 20%